Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension

European Respiratory Journal

Volumn 45, Issue 6, 2015, Pages 1737-1740

  Manders, Emmy ^a   Ruiter, Gerrina ^a   Bogaard, Harm Jan ^a   Stienen, Ger J M ^a,b   Vonk Noordegraaf, Anton ^a   De Man, Frances S ^a   Ottenheijm, Coen A C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EXERCISE; FEMALE; HUMAN; HUMAN TISSUE; LETTER; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE WEAKNESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUADRICEPS FEMORIS MUSCLE; SARCOMERE; VASTUS LATERALIS MUSCLE; AGED; CASE CONTROL STUDY; COMPLICATION; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

AGED; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE WEAKNESS; QUADRICEPS MUSCLE; SARCOMERES;

EID: 84930406349     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00205114     Document Type: Letter

References (15)

1. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
2. Kabitz H-J, Schwoerer A, Bremer H-C, et al. Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci 2008; 114: 165-171.
3. Mainguy V, Maltais FF, Saey D, et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 2010; 65: 113-117.
4. Potus F, Malenfant S, Graydon C, et al. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med 2014; 190: 318-328.
5. Mereles D, Elkhen N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114: 1482-1489.
6. De Man FS, Handoko ML, Groepenhoff H, et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2009; 34: 669-675.
7. Batt J, Ahmed SS, Correa J, et al. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 2014; 50: 74-86.
8. De Man FS, van Hees HW, Handoko ML, et al. Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: 1411-1418.
9. Manders E, de Man FS, Handoko ML, et al. Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction. Am J Physiol Lung Cell Mol Physiol 2012; 303: L1070-L1078.
10. D'Antona G, Pellegrino MA, Adami R, et al. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol 2003; 552: 499-511.
11. Udaka J, Ohmori S, Terui T, et al. Disuse-induced preferential loss of the giant protein titin depresses muscle performance via abnormal sarcomeric organization. J Gen Physiol 2008; 131: 33-41.
12. Llewellyn ME, Barretto RP, Delp SL, et al. Minimally invasive high-speed imaging of sarcomere contractile dynamics in mice and humans. Nature 2008; 454: 784-788.
13. Fukuda N, Wu Y, Farman G, et al. Titin-based modulation of active tension and interfilament lattice spacing in skinned rat cardiac muscle. Pflugers Arch 2005; 449: 449-457.
14. Hooijman P, Beishuizen A, de Waard M, et al. Diaphragm fiber strength is reduced in critically ill patients and restored by a troponin activator. Am J Respir Crit Care Med 2014; 7: 863-865.
15. Russell AJ, Hartman JJ, Hinken AC, et al. Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases. Nat Med 2012; 18: 452-455.